RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,334 filers reported holding RAYTHEON CO in Q1 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,791,000 | +135.1% | 97,527 | +293.9% | 0.17% | +147.1% |
| Q4 2019 | $5,440,000 | +60.9% | 24,760 | +43.6% | 0.07% | +47.8% |
| Q3 2019 | $3,382,000 | +228.3% | 17,239 | +191.1% | 0.05% | +228.6% |
| Q2 2019 | $1,030,000 | -26.6% | 5,923 | -23.2% | 0.01% | -30.0% |
| Q1 2019 | $1,404,000 | +418.1% | 7,709 | +336.3% | 0.02% | +300.0% |
| Q4 2018 | $271,000 | -61.7% | 1,767 | -48.4% | 0.01% | -54.5% |
| Q3 2018 | $708,000 | -12.2% | 3,427 | -17.8% | 0.01% | -15.4% |
| Q2 2018 | $806,000 | +3.7% | 4,169 | +15.8% | 0.01% | 0.0% |
| Q1 2018 | $777,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |